Rxsight (RXST)See remarks sold ~$14K

~$14K

Approx. value · 2,041 sh @ $6.96

200K

Holds after · shares reported

Traded

Sep 2, 2026

Filed

Sep 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 30, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
2. Jul 6, 2026Company filing · Form 8-K · ResultsReported its results
3. Jul 13, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 13, 2026, the Board of Directors (the “Board”) of RxSight, Inc. (the “Company”) appointed Aziz Mottiwala to serve as the Company’s President and Chief Executive Officer, effective as of Mr. Mottiwala’s first day of employment with the Company, which is expected to be July 20, 2026 (the “Effective Date”), replacing Ron Kurtz, M.D. in such roles.”
4. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
5. Sep 2, 2026 · this disclosureInsiderOfficer sold ~$14K of RXST shares in the open market

What came next

1. Sep 2, 2026Insider · 3 peopleInsiders: 3 sales (~$104K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Rxsight

For Rxsight, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RXST page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Rxsight

• SEC Form 4Sep 3, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 13F-HRAug 14, 2025
• SEC Form 13F-HRAug 14, 2025

Everything OQRO holds on this company is on its RXST page.